Prota Therapeutics Pty Ltd

About Prota Therapeutics Pty Ltd

Prota Therapeutics is a late clinical-stage biotech company focused on advancing allergen oral immunotherapies for treating food allergies, with a particular emphasis on peanut allergies. Their mission is to provide long-lasting peace of mind to food allergy sufferers, aiming to enhance the quality of life for affected patients through innovative treatments.

Products & Services

PRT120:A phase-3 ready lead product specifically targeting peanut allergy, designed to address this serious and potentially life-threatening condition.

Specialties

Allergen Oral Immunotherapy Food Allergy Treatment Peanut Allergy Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Equity and Debt T: - FT: Equity and Debt	A: 21000000 MR: - FA: US$21 million FAN: 21000000	D: 2024-01-16 FD: 2024-01-16	2 investors

Equity and Debt Latest

2024-01-16

$21.0M

2 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

M

Mimi Tang

Professor

M

Mark Hasleton

Acting CEO

C

Cameron Jones

Chief Financial Officer

K

Kathy Harrison

Director, Intellectual Property

B

Bronwyn Pollock

Product Development Technical Services - Consultant

L

Lesley White

Regulatory Affairs & CMC

View 9 more team members with Pro

Unlock Full Team Directory

Recent News